Evidence map›Paper›PMID 42433663›Full record

ArticleKidney international reports2026

Randomized Controlled Clinical Trial of Allogeneic Mesenchymal Stromal Cell Infusion in Diabetic Kidney Disease.

Norberto Perico, Matthew D Griffin, Giuseppe Remuzzi, Paul Cockwell, Alexander P Maxwell, Monica Cortinovis, Federica Casiraghi, Nadia Rubis, Tobia Peracchi, Alessandro Villa and 20 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Norberto PericoCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò", Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Matthew D GriffinDiscipline of Advanced Therapies and Regenerative Medicine Institute at CÚRAM Research Ireland Centre for Medical Devices, School of Medicine, University of Galway, Ireland.
Giuseppe RemuzziCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò", Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Paul CockwellDepartment of Renal Medicine, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Alexander P MaxwellCentre for Public Health, Queen's University Belfast, Belfast, UK.
Monica CortinovisCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò", Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Federica CasiraghiCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò", Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Nadia RubisCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò", Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Tobia PeracchiCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò", Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Alessandro VillaCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò", Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Davide MartinettiCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò", Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Marta TodeschiniCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò", Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Fabiola CarraraCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò", Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Bernadette A MageeNorthern Ireland Histocompatibility and Immunogenetics Laboratory, Belfast City Hospital, Belfast, Northern Ireland.
Piero L RuggenentiUnit of Nephrology and Dialysis, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
Stefano RotaUnit of Nephrology and Dialysis, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
Laura CappellettiUnit of Nephrology and Dialysis, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
Veronica McInerneyDiscipline of Advanced Therapies and Regenerative Medicine Institute at CÚRAM Research Ireland Centre for Medical Devices, School of Medicine, University of Galway, Ireland.
Tomás P GriffinDiscipline of Advanced Therapies and Regenerative Medicine Institute at CÚRAM Research Ireland Centre for Medical Devices, School of Medicine, University of Galway, Ireland.
Md Nahidul IslamDiscipline of Advanced Therapies and Regenerative Medicine Institute at CÚRAM Research Ireland Centre for Medical Devices, School of Medicine, University of Galway, Ireland.
Martino IntronaCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò", Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Olga PedriniAzienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
Josée GolayAzienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
Andrew A FinnertyDiscipline of Advanced Therapies and Regenerative Medicine Institute at CÚRAM Research Ireland Centre for Medical Devices, School of Medicine, University of Galway, Ireland.
Jon SmytheCellular and Molecular Therapies, NHS Blood and Transplant, Oxford, UK.
Willem E FibbeDepartment of Internal Medicine and Nephrology, Leiden University Medical Center, Leiden, the Netherlands.
Stephen J EllimanOrbsen Therapeutics Ltd, Galway, Ireland.
Timothy O'BrienDiscipline of Advanced Therapies and Regenerative Medicine Institute at CÚRAM Research Ireland Centre for Medical Devices, School of Medicine, University of Galway, Ireland.
NEPHSTROM Trial Consortium15
NEPHSTROM Trial Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diabetic kidney diseaseglomerular filtration rateimmune modulationrandomized controlled trialsstem cellstype 2 diabetes

Identifiers

PMID42433663
PMCPMC13352012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.